Abstract
In 2014 the World Health Organization classification of female genital tract tumors was revised and published to employ the histopathologic term squamous intraepithelial lesion (SIL), which the Bethesda system had introduced to standardize cytology reporting in 1988. This revision reflects a paradigm shift in the views regarding the morphological and biological aspects of precancerous squamous lesions of the uterine cervix. Low-grade SIL is defined as productive human papillomavirus (HPV) infection, whereas high-grade SIL represents a neoplastic condition resulting from transformation owing to the integration of HPV DNA into the host genome. Currently, a variety of ancillary methods, including immunohistochemistry (IHC), contribute to establishing a correct diagnosis or optimal management for women with SIL. For example, a combination of Ki-67 and p16INK4a IHC, as well as HPV IHC or in situ hybridization, is routinely used to facilitate diagnosis. In this chapter, current concepts, controversies, and diagnostic strategies for SIL are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rubin IC. The pathological diagnosis of incipient carcinoma of the uterus. Am J Obstet. 1910;62:668–76.
Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA. 1932;99:1670–4.
Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer. 1953;6(2):224–34.
Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol. 1969;105(3):386–93.
Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983;80(12):3812–5.
Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A. 1983;80(2):560–3.
Crum CP, Ikenberg H, Richart RM, Gissman L. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med. 1984;310(14):880–3. https://doi.org/10.1056/NEJM198404053101403.
Winkler B, Crum CP, Fujii T, Ferenczy A, Boon M, Braun L, Lancaster WD, Richart RM. Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer. 1984;53(5):1081–7.
The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. Developed and approved at a National Cancer Institute workshop, Bethesda, Maryland, USA, December 12-13, 1988. J Reprod Med. 1989;34(10):779–85.
Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC, Members of the LPWG. The lower Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013;32(1):76–115. https://doi.org/10.1097/PGP.0b013e31826916c7.
Kurman RJ, International Agency for Research on Cancer, World Health Organization. WHO classification of tumours of female reproductive organs. World Health Organization classification of tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2014.
Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM, New Mexico HPVPRSC. Cervical histopathology variability among laboratories: a population-based statewide investigation. Am J Clin Pathol. 2013;139(3):330–5. https://doi.org/10.1309/AJCPSD3ZXJXP7NNB.
Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Gilioli E, Onnis GL, Aldovini D, Galanti G, Casadei G, Aldi M, Gomes VV, Giubilato P, Ronco G, Group NP. The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. Am J Clin Pathol. 2009;132(1):125–32. https://doi.org/10.1309/AJCPBRK7D1YIUWFP.
Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, American Society for Colposcopy and Cervical Pathology-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197(4):340–5. https://doi.org/10.1016/j.ajog.2007.07.050.
Stoler M, Bergeron C, Colgan TJ, Ferenczy AS, Herrington CS, Kim KR, Loening T, Schneider A, Sherman ME, Wilbur DC, Wright T. Squamous cell tumors and precursors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. Lyon: IARC; 2014.
Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC, Members of LPWG. The lower Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16(3):205–42. https://doi.org/10.1097/LGT.0b013e31825c31dd.
Cho NH, Kang S, Hong S, Jeong GB, Choi IW, Choi HJ, Choi HK. Multinucleation of koilocytes is in fact multilobation and is related to aberration of the G2 checkpoint. J Clin Pathol. 2005;58(6):576–82. https://doi.org/10.1136/jcp.2004.022152.
Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. One virus, one lesion—individual components of CIN lesions contain a specific HPV type. J Pathol. 2012;227(1):62–71. https://doi.org/10.1002/path.3970.
Nagura M, Koshiyama M, Matsumura N, Kido A, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Mikami Y, Konishi I. Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:784. https://doi.org/10.1186/1471-2407-14-784.
Mittal K. Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix. Adv Anat Pathol. 1999;6(4):177–85.
Konishi I, Fujii S, Nonogaki H, Nanbu Y, Iwai T, Mori T. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer. 1991;68(6):1340–50.
Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol. 2005;29(5):674–9. doi: 00000478-200505000-00015 [pii].
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92(2):276–84. https://doi.org/10.1002/ijc.1174. [pii].
Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res. 2004;10(7):2407–14.
Queiroz C, Silva TC, Alves VA, Villa LL, Costa MC, Travassos AG, Filho JB, Studart E, Cheto T, de Freitas LA. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol Res Pract. 2006;202(2):77–83. doi:S0344-0338(05)00216-5 [pii]. https://doi.org/10.1016/j.prp.2005.08.012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mikami, Y. (2018). A New Strategy for Diagnosing of Squamous Intraepithelial Neoplasia of the Cervix. In: Moriya, T. (eds) Pathology of Female Cancers. Springer, Singapore. https://doi.org/10.1007/978-981-10-8606-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-10-8606-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8605-2
Online ISBN: 978-981-10-8606-9
eBook Packages: MedicineMedicine (R0)